Company To Pay 40M Over Allegations It Raised Price Of Exclusive Drug By 4000 Percent
After obtaining rights to Daraprim in 2015, Vyera raised the price from $17.50 to $750 per pill. This left some patients paying as much as $16,000 in co-payments. The lawsuit also accused Vyera of preventing competitors from making a cheaper generic version of the drug, creating a “a web of anticompetitive restrictions.” The drug is used to treat toxoplasmosis, a disease resulting from infection with Toxoplasma gondii, a common parasite....